Although metallothioneins (MTs) were discovered nearly 40 years ago, their functional role has still not been completely clarified. The role of MTs in the central nervous system has in particular become an intense focus of scientific research. Many papers have confirmed the active and peculiar role played by these proteins in neurodegenerative disorders, even if contrasting results are still present. The involvement of MTs in various neurodegenerative diseases (Alzheimer's disease, frontotemporal dementia, Binswanger's disease, Parkinson's disease, amyotrophic lateral sclerosis, and prion protein disease) is herein reported.